Shots:

• J&J temporarily pause the use of the COVID-19 vaccine in the US- following recommended of the CDC and FDA. The review data involves six reported cases of a rare and severe type of blood clot in the US after receiving the J&J vaccine
• The pause is due to the unusual clotting in 6 women aged 18-48 with symptoms occurring in 6-13 days after vaccination- in combination with reduced platelet counts. Additionally- J&J delay the rollout of the vaccine in the EU and pause vaccinations in all COVID-19 vaccine clinical trials
• The similar blood clot problem seen in AstraZeneca’s COVID 19 vaccine- as reported by several EU countries which prompted curbs to its use

Source 1 - Source 2  Ref: J&J | Image: Reuters